Development of miRNA-mimic nanoparticles for the treatment of brain tumours
Publication Date
July 17, 2017
Abstract
Glioblastoma are aggressive brain tumours with a median survival of 15 months even with the best currently available treatment options. microRNAs (miRNA) are ~23 nucleotide natural silencing RNAs that have great potentials to improve cancer treatment outcomes. Lack of a safe, stable and efficient delivery system has, however, hindered the use of miRNAs in clinical applications. The aim is therefore to develop a miRNA delivery system adapted to glioblastoma using linear chain cationic polyamidoamine (PAA) polymers. The first part involved the development of luciferase assay that combined the measurement of gene-knockdown efficiency and cytotoxicity of miRNA nanoparticles. The simple two-step procedure was more effective and sensitive compared to the conventional protein-based normalization method. The second part was focused on the development of miRNA nanoparticles. In the initial phase, conditions required for maximum miRNA-polymer binding was achieved, however, the newly developed miRNA-PAA-nanoparticles did not produce significant functional gene-knockdown after cell treatment. The second stage was focused on the optimization of nanoparticle formulation as a function of stability in physiological ionic concentration. Stable PAA-nanoparticles displaying moderate cellular uptake and gene-knockdown were obtained. The final stage of development was focused on PAA-nanoparticle tagging with biotin, which improved their cellular uptake. This work developed simple and informative luciferase assay; the stability of miRNA-PAA-nanoparticles was improved by thiol-crosslinking and the cellular uptake was enhanced by a simple but smart method of ligand tagging. Further optimizations are needed to increase the functional performance of these potential and clinically relevant thiol-stabilized RNAi vectors.
Item Type
ethesis
Thesis Type
PhD
Supervisors
Subjects (LC)
Associated Schools / Departments
School of Pharmacy (UK)
eprints ID
39449
UoN Repository URI
Except where otherwise noted, this item's license is described as
File(s)![Thumbnail Image]()
![Thumbnail Image]()
Name
Final Thesis UoN SA.pdf
Type
Full-text
Description
Examined. Full Thesis - For Jury and Public
Size
14.71 MB
Format
Adobe PDF
Checksum (MD5)
bc21ddf99f770e1999fa1bba4350c184
Name
00-Comments and Actions Taken.pdf
Type
Full-text
Description
Examined. Jury's Comments and Actions Taken (ONLY for Jury)
Size
595.27 KB
Format
Adobe PDF
Checksum (MD5)
384f0179954edf479f99773b1a267cb0